These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37273119)

  • 1. Evaluation of a Community COVID-19 Vaccine Ambassador Train-the-Trainer Program.
    Corley AMS; Gomes SM; Martin KJ; Watkins S; Lindsey K; Frenck RW; Mitchell MJ; Rule ARL; Crosby LE
    J Immigr Minor Health; 2023 Dec; 25(6):1302-1306. PubMed ID: 37273119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing vaccine hesitancy and resistance for COVID-19 vaccines.
    Peters MDJ
    Int J Nurs Stud; 2022 Jul; 131():104241. PubMed ID: 35489108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Scope and Dimensions of Vaccine Hesitancy and Resistance to Enhance COVID-19 Vaccination in Black Communities.
    Okoro O; Kennedy J; Simmons G; Vosen EC; Allen K; Singer D; Scott D; Roberts R
    J Racial Ethn Health Disparities; 2022 Dec; 9(6):2117-2130. PubMed ID: 34553340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilizing faith-based COVID-19 health ambassadors to address COVID-19 health disparities among African American older adults in under-resourced communities: A hybrid, community-based participatory intervention.
    Adinkrah EK; Bazargan S; Cobb S; Kibe LW; Vargas R; Waller J; Sanchez H; Bazargan M
    PLoS One; 2024; 19(2):e0285963. PubMed ID: 38358995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaling and sustaining COVID-19 vaccination through meaningful community engagement and care coordination for underserved communities: hybrid type 3 effectiveness-implementation sequential multiple assignment randomized trial.
    Rabin BA; Cain KL; Watson P; Oswald W; Laurent LC; Meadows AR; Seifert M; Munoz FA; Salgin L; Aldous J; Diaz EA; Villodas M; Vijaykumar S; O'Leary ST; Stadnick NA
    Implement Sci; 2023 Jul; 18(1):28. PubMed ID: 37443044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing education: Personal communication with a healthcare professional is a critical step to address vaccine hesitancy for people with multiple sclerosis.
    Panisset MG; Kilpatrick T; Cofré Lizama LE; Galea MP
    Mult Scler Relat Disord; 2022 Jul; 63():103933. PubMed ID: 35671672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing COVID-19 vaccine hesitancy in rural communities: A case study in engaging trusted messengers to pivot and plan.
    Reichelt M; Cullen JP; Mayer-Fried S; Russell HA; Bennett NM; Yousefi-Nooraie R
    Front Public Health; 2023; 11():1059067. PubMed ID: 36844863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing COVID-19 inequities using bidirectional crisis and emergency risk communication and vaccine clinic interventions: a descriptive study.
    Lohr AM; Neumbo KC; Njeru JW; Molina L; Hasley R; Ahmed Y; Quirindongo-Cedeno O; Torres-Herbeck GA; Goodson ML; Osman A; Weis JA; Wieland ML; Sia IG
    BMC Public Health; 2023 Aug; 23(1):1517. PubMed ID: 37558981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccine attitudes among a majority black sample in the Southern US: public health implications from a qualitative study.
    Huang W; Dove-Medows E; Shealey J; Sanchez K; Benson L; Seymore DD; Sullivan PS; Bradley HM; Siegler AJ
    BMC Public Health; 2023 Jan; 23(1):88. PubMed ID: 36631819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empowering Youth Vaccine Ambassadors to Promote COVID-19 Vaccination in Local Communities: A 7-Step Approach.
    Minkah PA; Borg A; Ryan GW; Goulding M; Perrone D; Castiel M; Rosal MC; Lemon SC
    Health Promot Pract; 2023 Jun; ():15248399231178542. PubMed ID: 37303187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
    Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
    Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing Baltimore: Creating Support for VALUE (Vaccine Access & Acceptance, Lives in Unity, Education & Engagement) Baltimore Ambassadors as They Serve During the COVID-19 Pandemic.
    Holt M; Ruiz-Aguilera E; Ngeno G; Bronner Y
    Health Promot Pract; 2024 Mar; 25(2):170-172. PubMed ID: 37073499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing COVID-19 Vaccine Hesitancy With Community Distribution of Conversation Cards.
    Kreuter MW; Butler T; Kinzer H; Carter T; Laker PA; Caburnay C; Olagoke A; Skinner K; Broadus D; Davis MH
    Am J Public Health; 2024 Jan; 114(S1):S87-S91. PubMed ID: 38207273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
    Wiysonge CS; Ndwandwe D; Ryan J; Jaca A; Batouré O; Anya BM; Cooper S
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 33684019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "They're trying to bribe you and taking away your freedoms": COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates.
    Capurro G; Maier R; Tustin J; Jardine CG; Michelle Driedger S
    Vaccine; 2022 Nov; 40(50):7280-7287. PubMed ID: 36334965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Offering onsite COVID-19 vaccination to high-risk obstetrical patients: initial findings.
    Hirshberg JS; Huysman BC; Oakes MC; Cater EB; Odibo AO; Raghuraman N; Kelly JC
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100478. PubMed ID: 34481996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community voices around COVID-19 vaccine in Chennai, India: A qualitative exploration during early phase of vaccine rollout.
    Kumar MS; Madhumathi J; Gayathri K; A Rozario AG; Vijayaprabha R; Balusamy M; Sonekar H; Panda S
    Indian J Med Res; 2022; 155(5&6):451-460. PubMed ID: 35975352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the beliefs and experiences with regard to COVID-19 vaccine hesitancy and acceptance in a slum of Karachi, Pakistan.
    Qasim R; Shah H; Sultan A; Yaqoob M; Haroon R; Mistry SK; Bestman A; Yousafzai MT; Yadav UN
    Health Promot Int; 2022 Dec; 37(6):. PubMed ID: 36300701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring key informants' perceptions of Covid-19 vaccine hesitancy in a disadvantaged urban community in Ireland: Emergence of a '4Cs' model.
    Ingram C; Roe M; Downey V; Phipps L; Perrotta C
    Vaccine; 2023 Jan; 41(2):519-531. PubMed ID: 36496286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using human-centred design to tackle COVID-19 vaccine hesitancy for children and youth: a protocol for a mixed-methods study in Montreal, Canada.
    McKinnon B; Abalovi K; Vandermorris A; Dubé È; Tuong Nguyen C; Billou N; Fortin G; Parvez M; Senga J; Abou-Malhab J; Antoine Bellamy M; Quach C; Zinszer K
    BMJ Open; 2022 Apr; 12(4):e061908. PubMed ID: 35383090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.